INIT Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Initiator Pharma A/S - Alpha Spread
I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.5 SEK 1.35% Market Closed
Market Cap: 396.9m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Wall Street
Price Targets

INIT Price Targets Summary
Initiator Pharma A/S

Wall Street analysts forecast INIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INIT is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.

Lowest
Price Target
24.24 SEK
223% Upside
Average
Price Target
24.48 SEK
226% Upside
Highest
Price Target
25.2 SEK
236% Upside
Initiator Pharma A/S Competitors:
Price Targets
HOWL
Werewolf Therapeutics Inc
416% Upside
IMM
Immutep Ltd
192% Upside
AURA
Aura Biosciences Inc
114% Upside
ELDN
Eledon Pharmaceuticals Inc
467% Upside
PANACEABIO
Panacea Biotec Ltd
79% Downside
HALO
Halozyme Therapeutics Inc
3% Upside
ARGX
argenx SE
7% Upside
ANIK
Anika Therapeutics Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Initiator Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Initiator Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Initiator Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INIT's stock price target?
Price Target
24.48 SEK

According to Wall Street analysts, the average 1-year price target for INIT is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.

Back to Top